Shield Therapeutics (STU:1JS) Total Tax Payable: €0.06 Mil (As of Dec. 2025)


What is Shield Therapeutics Total Tax Payable?

Shield Therapeutics STU:1JS +1.47% Total Tax Payable is €0.06 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

Shield Therapeutics's Total Tax Payable for the quarter that ended in Dec. 2025 was €0.06 Mil.

Shield Therapeutics's quarterly Total Tax Payable increased from Dec. 2024 (€0.05 Mil) to Jun. 2025 (€0.05 Mil) and increased from Jun. 2025 (€0.05 Mil) to Dec. 2025 (€0.06 Mil).

Shield Therapeutics's annual Total Tax Payable declined from Dec. 2023 (€0.09 Mil) to Dec. 2024 (€0.05 Mil) but then increased from Dec. 2024 (€0.05 Mil) to Dec. 2025 (€0.06 Mil).

Shield Therapeutics Total Tax Payable Related Terms

Shield Therapeutics Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Shield Therapeutics's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shield Therapeutics Total Tax Payable Chart

Shield Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Tax Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.26 0.09 0.05 0.06

Shield Therapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 3.44 0.05 0.05 0.06

Shield Therapeutics Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of €0.06 Mil mean?
Shield Therapeutics (STU:1JS) has a Total Tax Payable of €0.06 Mil as of Dec. 2025. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Shield Therapeutics and its competitors.
Is Shield Therapeutics' Total Tax Payable too high?
Shield Therapeutics' current Total Tax Payable is €0.06 Mil.
How does Shield Therapeutics' Total Tax Payable compare to ZTS and UTHR?
Shield Therapeutics' Total Tax Payable of €0.06 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Drug Manufacturers company?
A good Total Tax Payable depends on the Drug Manufacturers industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Shield Therapeutics and its competitors. Shield Therapeutics's current Total Tax Payable is €0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shield Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Shield Therapeutics (STU:1JS) is currently considered Possible Value Trap. The stock's GF Value™ is €0.10, compared to a current price of €0.07 — trading 31% below its estimated fair value. The current Total Tax Payable is €0.06 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Shield Therapeutics (STU:1JS), the current Total Tax Payable is €0.06 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shield Therapeutics Business Description

Other Exchanges SHIEF:USASTX:UK1JS:Germany
Address Gateshead Quays, Northern Design Centre, Baltic Business Quarter, Newcastle, GBR, NE8 3DF
Shield Therapeutics PLC is a commercial-stage specialty pharmaceutical company that delivers ACCRUFeR/FeRACCRU (ferric maltol), a differentiated pharmaceutical product, to address the unmet need for patients suffering from iron deficiency, with or without anemia. The company has launched ACCRUFeR in the U.S. Outside of the U.S., it has licensed the rights to specialty pharmaceutical companies. FeRACCRU is commercialised in the UK, the European Union, and Canada, with marketing rights in Australia and New Zealand. The company's operating segments are: FeRACCRU, which generates the maximum revenue, and PT20. Geographically, it generates maximum revenue from the U.S., and the rest from the Netherlands, Canada, Japan, and South Korea.